Juan Pablo Udry, general manager Brazil and Latin America at Boiron, the world’s undisputed leader in homeopathic medicines, provides an insightful overview of the Brazilian and Latin American landscape for homeopathic products and documents Boiron’s commitment to bringing a new alternative to physicians across the continent. He also describes the company’s differentiated and successful market approach in Brazil and Latin America, as well as his expectations regarding the evolution of Brazil’s regulatory framework for homeopathy.
You were appointed in July 2017 as general manager for Latin America & Brazil, almost two years after taking over Boiron’s Brazilian operations. Given that some of the region’s largest countries have recently experienced political and economic difficulties; can we say that Latin America is still a region of opportunities for a company like Boiron?
"Although we remain relatively small in terms of sales, Brazil has already become a strategic market for Boiron, where some innovative, pilot projects are currently under development."
